The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new ...

Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial ...

Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to expedite drug development, while continuing to advance its ...

Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...

The Food and Drug Administration (FDA) has recently issued two draft guidance documents aimed at providing recommendations for the use of AI ...

Manas AI Inc., a startup using artificial intelligence to discover new medicines, launched today with $24.6 million in ...

Servier isn’t the first drug developer to spot a silver lining in Google Cloud. Ginkgo inked its own five-year partnership in ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...